Corrections to substituted terphenyl compounds as the first class of low molecular weight allosteric inhibitors of the luteinizing hormone receptor (Journal of Medicinal Chemistry (2009) 52, (2036) DOI: 10.1021/jm801561h);Substituted terphenyl compounds as the first class of low molecular weight allosteric inhibitors of the luteinizing hormone receptor

Journal of Medicinal Chemistry

Volumn 52, Issue 7, 2009, Pages 2036-2042

  Heitman, Laura H ^a   Narlawar, Rajeshwar ^a   De Vries, Henk ^a   Willemsen, Milou N ^a   Wolfram, Dieter ^a   Brussee, Johannes ^a   IJzerman, Adriaan P ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

4 METHYL 1,1',3',1'' TERPHENYL 5' YL CYCLOPENTYLCARBAMATE; CYCLOPENTYLCARBAMIC ACID[1,1',3',1'']TERPHENYL 5' YL ESTER; HORMONE RECEPTOR BLOCKING AGENT; LUF 5771; LUTEINIZING HORMONE RECEPTOR; LUTEINIZING HORMONE RECEPTOR INHIBITOR; PHENYLCARBAMIC ACID[1,1',3',1'']TERPHENYL 5' YL ESTER; TERPHENYL DERIVATIVE; UNCLASSIFIED DRUG;

ALLOSTERISM; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; NONHUMAN; STRUCTURE ACTIVITY RELATION;

EID: 64549104810     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm901700k     Document Type: Erratum

References (27)

1. Vassart, G.; Pardo, L.; Costagliola, S. A molecular dissection of the glycoprotein hormone receptors. Trends Biochem. Sci. 2004, 29, 119-126.
2. Smits, G.; Campillo, M.; Govaerts, C.; Janssens, V.; Richter, C.; Vassart, G.; Pardo, L.; Costagliola, S. Glycoprotein hormone receptors: determinants in leucine-rich repeats responsible for ligand specificity. EMBO J. 2003, 22, 2692-2703.
3. Loumaye, E.; Martineau, I.; Piazzi, A.; O'Dea, L.; Ince, S.; Howles, C.; Decosterd, G.; Van Loon, K.; Galazka, A. Clinical assessment of human gonadotrophins produced by recombinant DNA technology. Hum. Reprod. 1996, 11 Suppl. 1, 95-107.
4. Van de Lagemaat, R.; Timmers, C. M.; Kelder, J.; Van Koppen, C.; Mosselman, S.; Hanssen, R. G. Induction of ovulation by a potent, orally active, low molecular weight agonist (Org 43553) of the luteinizing hormone receptor. Hum. Reprod. 2009, 24 (3), 640-648.
5. Roy, S.; Setlur, S.; Gadkari, R. A.; Krishnamurthy, H. N.; Dighe, R. R. Translational fusion of two -subunits of human chorionic gonadotropin results in production of a novel antagonist of the hormone. Endocrinology 2007, 148, 3977-3986.
6. Heitman, L. H.; IJzerman, A. P. G protein-coupled receptors of the hypothalamic-pituitary-gonadal axis: A case for GnRH, LH, FSH, and GPR54 receptor ligands. Med. Res. Rev. 2008, 28, 975-1011.
7. Choi, J. H.; Wong, A. S.; Huang, H. F.; Leung, P. C. Gonadotropins and ovarian cancer. Endocr. Rev. 2007, 28, 440-461.]
8. 3H]Org 43553, the First Low-Molecular-Weight Agonistic and Allosteric Radioligand for the Human Luteinizing Hormone Receptor. Mol. Pharmacol. 2008, 73, 518-524.
9. Kostenis, E.; Mohr, K. Two-point kinetic experiments to quantify allosteric effects on radioligand dissociation. Trends Pharmacol. Sci. 1996, 17, 280-283.
10. Miyaura, N.; Suzuki, A. Palladium-catalyzed cross-coupling reactions of organoboron compounds. Chem. Rev. 1995, 95, 2457-2483.
11. Bharathi, P.; Patel, U.; Kawaguchi, T.; Pesak, D. J.; Moore, J. S. Improvements in the synthesis of phenylacetylene monodendrons including a solid-phase convergent method. Macromolecules 1995, 28, 5955-5963.
12. Chang, L. C. W.; Spanjersberg, R. F.; von Frijtag Drabbe Kunzel, J. K.; Mulder-Krieger, T.; van den Hout, G.; Beukers, M. W.; Brussee, J.; IJzerman, A. P. 2,4,6-Trisubstituted pyrimidines as a new class of selective adenosine A1 receptor antagonists. J. Med. Chem. 2004, 47, 6529-6540.
13. Chang, L. C. W.; von Frijtag Drabbe Kunzel, J. K.; Mulder-Krieger, T.; Westerhout, J.; Spangenberg, T.; Brussee, J.; IJzerman, A. P. 2,6,8- Trisubstituted 1-deazapurines as adenosine receptor antagonists. J. Med. Chem. 2007, 50, 828-834.
14. Mantri, M.; de Graaf, O.; van Veldhoven, J.; Göblyos, A.; von Frijtag Drabbe Kunzel, J. K.; Mulder-Krieger, T.; Link, R.; de Vries, H.; Beukers, M. W.; Brussee, J.; IJzerman, A. P. 2-Amino-6-furan-2-yl-4-substituted nicotinonitriles as A2A adenosine receptor antagonists. J. Med. Chem. 2008, 51, 4449-4455.
15. Heitman, L. H.; Ye, K.; Oosterom, J.; Ijzerman, A. P. Amiloride derivatives and a nonpeptidic antagonist bind at two distinct allosteric sites in the human gonadotropin-releasing hormone receptor. Mol. Pharmacol. 2008, 73, 1808-1815.
16. Van der Klein, P. A.; Kourounakis, A. P.; IJzerman, A. P. Allosteric modulation of the adenosine A1 receptor. Synthesis and biological evaluation of novel 2-amino-3-benzoylthiophenes as allosteric enhancers of agonist binding. J. Med. Chem. 1999, 42, 3629-3635.
17. Göblyös, A.; Gao, Z. G.; Brussee, J.; Connestari, R.; Santiago, S. N.; Ye, K.; IJzerman, A. P.; Jacobson, K. A. Structure-activity relationships of new 1Himidazo[4,5-c]quinolin-4-amine derivatives as allosteric enhancers of the A3 adenosine receptor. J. Med. Chem. 2006, 49, 3354-3361.
18. Price, M. R.; Baillie, G. L.; Thomas, A.; Stevenson, L. A.; Easson, M.; Goodwin, R.; McLean, A.; McIntosh, L.; Goodwin, G.; Walker, G.; Westwood, P.; Marrs, J.; Thomson, F.; Cowley, P.; Christopoulos, A.; Pertwee, R. G.; Ross, R. A. Allosteric modulation of the cannabinoid CB1 receptor. Mol. Pharmacol. 2005, 68, 1484-1495.
19. Van Koppen, C.; Zaman, G.; Timmers, C.; Kelder, J.; Mosselman, S.; van de Lagemaat, R.; Smit, M. J.; Hanssen, R. A signaling-selective, nanomolar potent allosteric low molecular weight agonist for the human luteinizing hormone receptor. Naunyn Schmiedeberg's Arch. Pharmacol. 2008, 378, 503-514.
20. May, L. T.; Leach, K.; Sexton, P. M.; Christopoulos, A. Allosteric modulation of G protein-coupled receptors. Annu. Rev. Pharmacol. Toxicol. 2007, 47, 1-51.
21. Figler, H.; Olsson, R. A.; Linden, J. Allosteric enhancers of A1 adenosine receptors increase receptor-G protein coupling and counteract guanine nucleotide effects on agonist binding. Mol. Pharmacol. 2003, 64, 1557-1564.
22. Binet, V.; Brajon, C.; Le Corre, L.; Acher, F.; Pin, J.-P.; Prezeau, L. The heptahelical domain of GABAB2 is activated directly by CGP7930, a positive allosteric modulator of the GABAB receptor. J. Biol. Chem. 2004, 279, 29085-29091.
23. Langmead, C. J.; Fry, V. A. H.; Forbes, I. T.; Branch, C. L.; Christopoulos, A.; Wood, M. D.; Herdon, H. J. Probing the molecular mechanism of interaction between 4-n-butyl-1-[4-(2-methylphenyl)- 4-oxo-1-butyl]-piperidine (AC-42) and the muscarinic M1 receptor: direct pharmacological evidence that AC-42 is an allosteric agonist. Mol. Pharmacol. 2006, 69, 236-246.
24. Schwartz, T. W.; Holst, B. Ago-allosteric modulation and other types of allostery in dimeric 7TM receptors. J. Recept. Signal Transduction 2006, 26, 107-128.
25. Schwartz, T. W.; Holst, B. Allosteric enhancers, allosteric agonists and ago-allosteric modulators: where do they bind and how do they act? Trends Pharmacol. Sci. 2007, 28, 366-373.
26. Hanssen, R. G. J. M.; Timmers, C. M. Preparation of thieno[2,3-d]- pyrimidines with combined LH and FSH agonistic activity. WO 2003020726, 2003.
27. Lombardo, F.; Shalaeva, M. Y.; Tupper, K. A.; Gao, F. ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds. J. Med. Chem. 2001, 44, 2490-2497.